搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
FierceBiotech
1 小时
Sanofi lifts lid on MS data behind tolebrutinib’s mixed phase 3 scorecard, plans ‘24 ...
Sanofi has shared data from the phase 3 HERCULES trial that could rescue its multiple sclerosis (MS) drug candidate ...
FierceBiotech
4 小时
Edgewise's stock jumps 50% on the back of safety data for potential heart disease rival to ...
Edgewise Therapeutics's hypertrophic cardiomyopathy (HCM) asset has started off with a bang after early safety data sent the ...
FierceBiotech
22 小时
In 2 papers, researchers describe potential new neurodegenerative disease treatment approach
William McEwan, Ph.D., spent years unraveling how an antiviral protein, tripartite motif-containing 21 (TRIM21), protects our ...
FierceBiotech
20 小时
Jury rules for Axonics in Medtronic’s long-running neuromodulation patent lawsuit
A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...
FierceBiotech
23 小时
Achilles drops cell therapy program, braces for layoffs after missing 'commercial viability ...
Achilles Therapeutics has torn up its strategy. The British biotech is stopping work on its clinical-phase cell therapy, ...
FierceBiotech
23 小时
Aligos' MASH prospect slashes liver fat in phase 2, but stock drops anyway
Aligos Therapeutics is heralding a midstage win in metabolic-dysfunction associated steatohepatitis (MASH) after three ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈